Allergy and Infectious Diseases Research in Washington
CFDA 93.855 — federal program obligations to Washington
Total obligated
$3.45B
Awards
571
USAspending.gov records $3,362,694,848.29 in Allergy and Infectious Diseases Research obligations (CFDA 93.855) with place of performance in Washington, across 547 awards. Dividing that total by 547 yields about $6.15 million per award. This page is the 93.855 × WA join, not a ranking of Seattle laboratories and not a claim that every infectious-disease dollar in the state sits under this CFDA. Obligations are commitments, not outlays.
Key figures
- CFDA 93.855 shows $3,362,694,848.29 in Washington obligations on 547 awards.
- Mean obligation is about $6.15 million per award.
- WA is Washington State, not the District of Columbia.
- The cell is program 93.855 × state WA, not all health research in the state.
- Figures are USAspending obligations, not outlays.
The research catalog in Washington State
CFDA 93.855 (ALLERGY AND INFECTIOUS DISEASES RESEARCH) plus Washington place of performance produces $3,362,694,848.29 on 547 awards. The national program table is unfiltered by state. The Washington spending table is unfiltered by CFDA. Only the overlap belongs on this tie.
Five hundred forty-seven awards is a substantial instrument count for a research catalog. Dollars still sit in the billions because the mean obligation is high. The join does not split Seattle from Spokane and does not name institutes. Packet facts are the dollar total, award count, state WA, and CFDA 93.855.
Readers sometimes treat a large CFDA–state total as if it were a budget line the state legislature passed. $3,362,694,848.29 is not that. It is the USAspending obligation sum on awards tagged 93.855 and WA. The overlay table at the program-in-state path is the same cell rendered as a page; this narrative is the join explained in prose. Nothing here ranks Washington against other states on need, performance, or politics.
WA is Washington State. A $3,362,694,848.29 research cell on 547 awards is not a D.C. total and not a Seattle-only map. The about $6.15 million mean sits in research-grant territory. Institute names and fiscal years are not in the facts.
Keeping 93.855 from swallowing other HHS lines
Cancer, aging, and other research catalogs use different CFDA numbers. Housing Choice Vouchers and Coronavirus Relief Fund, which also appear as Washington ties elsewhere, are different catalogs entirely. Adding any of them to $3,362,694,848.29 would invent a total this cell does not contain.
Available facts stop at $3,362,694,848.29, 547 awards, WA, and 93.855. Fiscal years, grant mechanisms, and recipient names are absent. The title is the catalog name, not a disease-prevalence statistic.
The only numeric facts on this packet are $3,362,694,848.29, 547 awards, CFDA 93.855, program title Allergy And Infectious Diseases Research, and geography WA/Washington. Any other dollar, year, recipient, or percentage would be invented. Trivial arithmetic from those facts is allowed: 547 awards into $3,362,694,848.29 is about $6.15 million per award. That quotient is a mean of records, not a typical household, student, or lab.
Washington State’s other large catalogs in this slice include vouchers, CRF, and transit capital. Adding them to $3,362,694,848.29 would invent a state total. This tie is 93.855 × WA only.
Full analysis: Allergy and Infectious Diseases Research obligations in Washington →
Questions
- How much CFDA 93.855 funding is obligated in Washington?
- USAspending records $3,362,694,848.29 in Allergy and Infectious Diseases Research obligations with Washington place of performance across 547 awards. That is the pair total, not the national program total and not an outlay.
- Is this Washington, D.C.?
- No. The state code is WA (Washington State). The $3,362,694,848.29 figure is the 93.855 × WA cell. District of Columbia spending uses a different geography tag.
- Is this all federal health research in Washington?
- No. Other research catalogs use other CFDA numbers. This page is 93.855 only.
- What is the average award?
- About $6.15 million ($3,362,694,848.29 ÷ 547). The mean is not a median and not a typical lab invoice.
USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.
How this pair fits
Explore related views: National Allergy and Infectious Diseases Research profile · All programs in Washington · All spending in Washington